This biotech stock is a top pick at Guggenheim

Markets Investing.com By Investing.com 07 Oct 2026 07:30 1 min read
This biotech stock is a top pick at Guggenheim

Covered in this story

Call it yourself

No calls on $PICK yet. A scorecard is a price target with a date and the working behind it — tracked, settled and scored in public.

Make the first call on Zinc →

Dalsna Finance is currently tracking 8 stories mentioning Zinc, the earliest published 25 Aug 2026.

Read the full story on Investing.com → Opens the original article on www.investing.com

Summary aggregated from Investing.com's public RSS feed. The full reporting belongs to Investing.com — please read it on their site.